Alnylam Pharmaceuticals, Inc.

NasdaqGS:ALNY Stock Report

Market Cap: US$30.8b

Alnylam Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:ALNY Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
25 Jun 24SellUS$370,747Jeffrey PoultonIndividual1,605US$235.19
25 Jun 24SellUS$485,773Pushkal GargIndividual2,103US$235.19
25 Jun 24SellUS$276,731Kevin FitzgeraldIndividual1,198US$235.19
25 Jun 24SellUS$370,747Tolga TangulerIndividual1,605US$235.19
25 Jun 24SellUS$1,917,475Yvonne GreenstreetIndividual8,301US$235.19
16 Feb 24SellUS$1,040,885Yvonne GreenstreetIndividual7,030US$149.03
16 Feb 24SellUS$149,397Tolga TangulerIndividual1,009US$149.03
16 Feb 24SellUS$149,099Jeffrey PoultonIndividual1,007US$149.03
16 Feb 24SellUS$193,666Pushkal GargIndividual1,308US$149.03
04 Aug 23SellUS$753,986Akshay VaishnawIndividual4,057US$189.31
04 Aug 23SellUS$753,986Yvonne GreenstreetIndividual4,057US$189.31
04 Aug 23SellUS$643,037Jeffrey PoultonIndividual3,460US$189.31
04 Aug 23SellUS$643,223Pushkal GargIndividual3,461US$189.31

Insider Trading Volume

Insider Buying: ALNY insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of ALNY?
Owner TypeNumber of SharesOwnership Percentage
Private Companies1,7350.00137%
State or Government87,3870.0691%
Individual Insiders468,2910.37%
General Public9,442,5057.46%
Institutions116,491,86092.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 74.23% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15.7%
Capital Research and Management Company
19,887,743US$4.8b-13.7%0.24%
9.48%
The Vanguard Group, Inc.
11,994,261US$2.9b0.42%0.05%
7.69%
FMR LLC
9,733,177US$2.4b-3.29%0.15%
7.13%
BlackRock, Inc.
9,025,007US$2.2b5.91%0.04%
5.7%
Wellington Management Group LLP
7,209,005US$1.8b-0.07%0.27%
5.24%
Baillie Gifford & Co.
6,623,577US$1.6b-4.93%0.71%
5.19%
T. Rowe Price Group, Inc.
6,558,657US$1.6b-5.08%0.14%
3.01%
Dodge & Cox
3,811,480US$927.4m3.73%0.28%
2.52%
State Street Global Advisors, Inc.
3,191,373US$776.5m2.34%0.03%
1.61%
Norges Bank Investment Management
2,039,798US$496.3m0%0.04%
1.58%
Geode Capital Management, LLC
2,001,718US$487.1m3.89%0.04%
1.2%
JP Morgan Asset Management
1,521,748US$370.3m-44.3%0.04%
1.09%
American Century Investment Management Inc
1,373,654US$334.2m231%0.18%
0.76%
Pictet Asset Management Limited
961,504US$234.0m8.57%0.16%
0.73%
Legal & General Investment Management Limited
921,195US$224.1m-1.05%0.04%
0.73%
Bellevue Asset Management AG
918,284US$223.4m3.72%2.52%
0.7%
UBS Asset Management AG
883,113US$214.9m6.2%0.03%
0.66%
Deep Track Capital, LP
832,310US$202.5m0%5.78%
0.62%
BNY Asset Management
789,937US$192.2m-4.65%0.04%
0.59%
Amundi Asset Management SAS
746,064US$181.5m4.83%0.04%
0.58%
Northern Trust Global Investments
739,584US$180.0m-3.26%0.03%
0.46%
Loomis Sayles & Company, L.P.
581,851US$141.6m-4.42%0.19%
0.46%
Squarepoint OPS LLC
580,441US$141.2m72.8%0.59%
0.4%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
506,757US$123.3m-6.75%0.03%
0.37%
TD Asset Management, Inc.
462,348US$112.5m-0.8%0.09%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.